ACCUDEL Trademark

Trademark Overview

On Thursday, May 3, 2012, a trademark application was filed for ACCUDEL with the United States Patent and Trademark Office. The USPTO has given the ACCUDEL trademark a serial number of 85615660. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 14, 2014. This trademark is owned by Imprimis Pharmaceuticals, Inc.. The ACCUDEL trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of topical creams and solutions that facilitate transdermal delivery and increase efficacy and absorption of a wide range of pharmaceuticals
accudel

General Information

Serial Number85615660
Word MarkACCUDEL
Filing DateThursday, May 3, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 14, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 16, 2012

Trademark Statements

Goods and ServicesDrug delivery agents consisting of topical creams and solutions that facilitate transdermal delivery and increase efficacy and absorption of a wide range of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 9, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImprimis Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameImprimis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSolana Beach, CA 92075

Trademark Events

Event DateEvent Description
Monday, July 14, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 14, 2014ABANDONMENT - NO USE STATEMENT FILED
Saturday, November 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 22, 2013EXTENSION 2 GRANTED
Wednesday, November 20, 2013EXTENSION 2 FILED
Wednesday, November 20, 2013TEAS EXTENSION RECEIVED
Friday, June 21, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 20, 2013EXTENSION 1 GRANTED
Tuesday, May 21, 2013EXTENSION 1 FILED
Wednesday, June 19, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 21, 2013TEAS EXTENSION RECEIVED
Thursday, May 16, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 16, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 11, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 23, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 23, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 16, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 16, 2012PUBLISHED FOR OPPOSITION
Wednesday, September 26, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 13, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 13, 2012ASSIGNED TO LIE
Monday, September 3, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 1, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 31, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 31, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 24, 2012NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, August 24, 2012PRIORITY ACTION E-MAILED
Friday, August 24, 2012PRIORITY ACTION WRITTEN
Thursday, August 23, 2012ASSIGNED TO EXAMINER
Wednesday, May 9, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 7, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

accudel delivery efficacy increase absorption range pharmaceuticals transdermal wide facilitate consisting